Spain Pharmaceuticals

Pharma Mar SA (PHM)

Track

Track

Pharma Mar SA experienced various insider trading transactions throughout early 2026. The most recent activity occurred on June 16, 2026, involving a purchase by a board member. Prior months saw mixed buying and selling patterns among executives and directors. No significant trades have been recorded within the last three months.
Ticker: PHM Exchange: MCE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Pharma Mar SA. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.7
SOLEDAD CUENCA MIRANDA CONSEJERA Director
Transaction date
Purchase
Price
168.32
Quantity 82,906
Value €2,717,539
2.5
MONTSERRAT ANDRADE DETRELL CONSEJERA Director
Transaction date
Purchase
Price
76.12
Quantity 21,433
Value €3,744,344
2.6
JOSÉ MARÍA FERNÁNDEZ SOUSA-FARO CONSEJERO (PRESIDENTE) Director
Transaction date
Purchase
Price
48.25
Quantity 50,040
Value €4,576,394
2.2
INÉS PÉREZ CALLEJA DIRECTORA DE CALIDAD Officer
Transaction date
Sale
Price
93.73
Quantity 211
Value €19,777
2.4
LUIS MORA CAPITÁN DIRECTOR GENERAL UNIDAD DE NEGOCIO DE ONCOLOGÍA Officer
Transaction date
Sale
Price
90.50
Quantity 811
Value €73,396
2.4
LUIS MORA CAPITÁN DIRECTOR GENERAL UNIDAD DE NEGOCIO DE ONCOLOGÍA Officer
Transaction date
Purchase
Price
81.57
Quantity 146
Value €11,909
2.7
SOLEDAD CUENCA MIRANDA CONSEJERA Director
Transaction date
Purchase
Price
81.00
Quantity 100
Value €8,100
2.7
SOLEDAD CUENCA MIRANDA CONSEJERA Director
Transaction date
Sale
Price
88.00
Quantity 75
Value €6,600
2.7
SOLEDAD CUENCA MIRANDA CONSEJERA Director
Transaction date
Purchase
Price
81.00
Quantity 75
Value €6,075
2.7
SOLEDAD CUENCA MIRANDA CONSEJERA Director
Transaction date
Purchase
Price
72.30
Quantity 70
Value €5,061
2.7
SOLEDAD CUENCA MIRANDA CONSEJERA Director
Transaction date
Purchase
Price
88.00
Quantity 215
Value €18,920
2.7
SOLEDAD CUENCA MIRANDA CONSEJERA Director
Transaction date
Sale
Price
92.00
Quantity 215
Value €19,780
2.2
EDUARDO SERRA REXACH (CONSEJERO) Director
Through EDUARDO SERRA Y ASOCIADOS, S.L., a closely affiliated person
Transaction date
Purchase
Price
83.05
Quantity 2,402
Value €199,486
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-16 B Purchase
2.7
SOLEDAD CUENCA MIRANDA

CONSEJERA

Director
82,906
168.32
€2,717,539 		82,906 168.32 €2,717,539
2026-06-15 2026-06-12 B Purchase
2.5
MONTSERRAT ANDRADE DETRELL

CONSEJERA

Director
21,433
76.12
€3,744,344 		21,433 76.12 €3,744,344
2026-04-22 2026-04-21 B Purchase
2.6
JOSÉ MARÍA FERNÁNDEZ SOUSA-FARO

CONSEJERO (PRESIDENTE)

Director
50,040
48.25
€4,576,394 		50,040 48.25 €4,576,394
2026-04-10 2026-04-10 S Sale
2.2
INÉS PÉREZ CALLEJA

DIRECTORA DE CALIDAD

Officer
211
93.73
€19,777 		211 93.73 €19,777
2026-04-10 2026-04-10 S Sale
2.3
MARÍA CONCEPCIÓN SANZ LÓPEZ

DIRECTORA LEGAL DE NEGOCIO

Officer
220
93.00
€20,460 		220 93.00 €20,460
2026-04-06 2026-03-27 S Sale
2.4
LUIS MORA CAPITÁN

DIRECTOR GENERAL UNIDAD DE NEGOCIO DE ONCOLOGÍA

Officer
811
90.50
€73,396 		811 90.50 €73,396
2026-04-06 2026-03-26 B Purchase
2.4
LUIS MORA CAPITÁN

DIRECTOR GENERAL UNIDAD DE NEGOCIO DE ONCOLOGÍA

Officer
146
81.57
€11,909 		146 81.57 €11,909
2026-03-24 2026-03-23 B Purchase
2.7
SOLEDAD CUENCA MIRANDA

CONSEJERA

Director
100
81.00
€8,100 		100 81.00 €8,100
2026-03-19 2026-03-17 S Sale
2.7
SOLEDAD CUENCA MIRANDA

CONSEJERA

Director
75
88.00
€6,600 		75 88.00 €6,600
2026-03-16 2026-03-12 B Purchase
2.7
SOLEDAD CUENCA MIRANDA

CONSEJERA

Director
75
81.00
€6,075 		75 81.00 €6,075
2025-11-11 2025-11-06 B Purchase
2.7
SOLEDAD CUENCA MIRANDA

CONSEJERA

Director
70
72.30
€5,061 		70 72.30 €5,061
2025-10-24 2025-10-24 B Purchase
2.8
FERNANDO MARTÍN-DELGADO SANTOS

CONSEJERO

Director
500
74.57
€37,285 		500 74.57 €37,285
2025-10-28 2025-10-23 B Purchase
2.8
ROSA MARÍA SÁNCHEZ-YEBRA ALONSO

CONSEJERA

Director
100
76.35
€7,635 		100 76.35 €7,635
2025-10-08 2025-10-07 B Purchase
2.7
SOLEDAD CUENCA MIRANDA

CONSEJERA

Director
215
88.00
€18,920 		215 88.00 €18,920
2025-09-22 2025-09-17 S Sale
2.7
SOLEDAD CUENCA MIRANDA

CONSEJERA

Director
215
92.00
€19,780 		215 92.00 €19,780
2025-06-09 2025-06-06 B Purchase
2.8
ROSA MARÍA SÁNCHEZ-YEBRA ALONSO

CONSEJERA

Director
100
83.10
€8,310 		100 83.10 €8,310
2025-06-09 2025-06-06 B Purchase
2.8
FERNANDO MARTÍN-DELGADO SANTOS

CONSEJERO

Director
100
83.81
€8,381 		100 83.81 €8,381
2025-06-05 2025-06-03 B Purchase
2.8
ROSA MARÍA SÁNCHEZ-YEBRA ALONSO

CONSEJERA

Director
100
89.51
€8,951 		100 89.51 €8,951
2025-06-05 2025-06-02 B Purchase
2.8
ROSA MARÍA SÁNCHEZ-YEBRA ALONSO

CONSEJERA

Director
100
87.60
€8,760 		100 87.60 €8,760
2025-05-22 2025-05-20 B Purchase
2.2
EDUARDO SERRA REXACH (CONSEJERO)
Through EDUARDO SERRA Y ASOCIADOS, S.L., a closely affiliated person Director
2,402
83.05
€199,486 		2,402 83.05 €199,486
Explore more

More insider trading research around Pharma Mar SA

More insider trades in Spain
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe